Edward B. Garon, MD, MS
Accepting new patients

Edward B. Garon, MD, MS

  • Thoracic Medical Oncology
Average rating: 4.9
(88 ratings)  
Santa Monica Cancer Care | 2020 Santa Monica Boulevard, Suite 600, Santa Monica, CA 90404

About

Dr. Garon received his MD degree from the Washington University School of Medicine in 1999, and his internal medicine training at the University of Chicago. He trained in Medical Oncology at UCLA, and joined the UCLA faculty in 2006. He also received a Masters' Degree in clinical investigation at UCLA. In 2008, he was appointed as an Assistant Professor of Medicine at the Geffen School of Medicine at UCLA in the Department of Medicine, Division of Hematology/Oncology and in 2014 he was promoted to Associate Professor of Medicine and he is now Professor of Medicine. Dr. Garon has been awarded the Diana Gordon Jonnson Award for Clinical Excellence in 2015. In addition to his clinical work, he also has an extensive focus in clinical and translational research. He has led studies that have led to FDA approvals of multiple drugs and companion diagnostic tests. He has received multiple foundations grants in addition to peer reviewed grants from governmental agencies, including NIH.

Languages

English

Education

Medical Board Certification

Medical Oncology, American Board of Internal Medicine, 2006

Fellowship

Hematology/Oncology, UCLA School of Medicine, 2006

Residency

Internal Medicine, University of Chicago Hospitals, 2002

Internship

Internal Medicine, University of Chicago Hospitals, 2000

Degree

MD, Washington University School of Medicine, 1999

Locations

Hospital Affiliations

Ronald Reagan UCLA Medical Center

UCLA Santa Monica Medical Center

Medical Services

Areas of Focus

Adenocarcinoma of lung
Squamous cancer of the lung
Small cell lung cancer
Non small cell lung cancer
Lung cancer
Egfr mutation

Videos

New Drug Offers Greater Hope for Some Patients with Lung Cancer | UCLA Vital Signs

Research

Interests

Dr. Edward Garon is interested in the testing and development of targeted therapies and immunotherapies in the treatment of non-small cell lung cancer.

Recognitions

  • Super Doctors® Southern California, 2022 - 2024